GlassScriptPhysician profile
Kirk A Philpot
NPI 1841294683
$1,902.07
in general payments reported to CMS, 2019-2025
21 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $691 · 2023: $474 · 2024: $448 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,211.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $262.77 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $229.24 | 2022-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $191.72 | 2022-2025 | Zerbaxa, Dificid, Recarbrio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $144.32 | 2023-2025 | Xifaxan |
| Melinta Therapeutics, LLC | $143.06 | 2022-2024 | Rezzayo, Orbactiv, Kimyrsa |
| Abbvie INC. | $137.83 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $134.42 | 2022-2023 | Camzyos |
| Amgen INC. | $117.08 | 2022-2024 | Repatha |
| Lilly USA, LLC | $86.22 | 2023 | Mounjaro |
| Alexion Pharmaceuticals, INC. | $58.50 | 2022-2023 | Ultomiris |
| Pfizer INC. | $58.22 | 2022 | |
| Insmed, INC. | $57.37 | 2025 | Arikayce |
| Stryker Corporation | $53.08 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Recor Medical INC | $50.90 | 2024 | Paradise Renal Denervation System |
| Smith+Nephew, INC. | $33.25 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $32.76 | 2023 | Watchman Access System |
| Abiomed | $26.56 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.44 | 2025 | Jardiance |
| Argenx US, INC. | $22.59 | 2023 | Vyvgart |
| Urgo Medical North America, LLC | $19.70 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Gilead Sciences, INC. | $16.04 | 2025 | Veklury |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Philpot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.